Related Experiment Videos
Application of proteomic technologies to tumor analysis
David E Misek1, Yugi Imafuku, Samir M Hanash
1Department of Pediatrics, University of Michigan, 1150 West Medical Center Drive, Ann Arbor, Michigan, 48109-0656, USA. dmisek@umich.edu
Pharmacogenomics
|December 9, 2004
Summary
Human genome sequencing advances cancer proteomic analysis, aiding biomarker discovery and personalized therapy development. New high-throughput technologies enhance protein identification for future breakthroughs.
Area of Science:
- Proteomics
- Genomics
- Cancer Biology
Background:
- The human genome sequence provides a foundation for understanding cancer proteomes in cells, tissues, and fluids.
- Neoplastic transformation processes and cancer biomarkers are of significant interest at the protein level.
Purpose of the Study:
- To explore the impact of genome sequencing on cancer proteomic analysis.
- To highlight the development of novel proteomic technologies for cancer research.
- To identify new biomarkers and therapeutic targets for cancer.
Main Methods:
- Leveraging the human genome sequence for proteomic analysis of cancer.
- Developing and applying high-throughput and high-sensitivity proteomic technologies.
- Separating and characterizing complex protein mixtures from cancer samples.
Main Results:
- Enhanced ability to analyze the human proteome in cancer.
- Improved separation and characterization of complex protein mixtures.
- Increased sensitivity in protein identification for cancer applications.
Conclusions:
- Genome sequencing has revolutionized cancer proteomic analysis.
- Innovative proteomic technologies are crucial for advancing cancer diagnostics and therapeutics.
- These advancements pave the way for personalized cancer therapy.